Kimia Biosciences share news, announcements and annual reports
BSE: 530313Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹30.45.
30 Oct: open ₹31.49, high ₹31.49, low ₹29.01
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹138 Cr2,580th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 19.20
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 7.79
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 51.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 19.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.95
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 237
Kimia Biosciences share news and announcements
546 announcements, routine notices left out, newest first. Page 7 of 11.
Sep 2020
Aug 2020
18 Aug · Board meeting
5 Aug · Board meeting
Meeting on 18 Aug 2020: quarterly results
Jul 2020
20 Jul · Shareholding for the Period Ended June 30, 2020
Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click ....18 Jul · Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 06 Jul · Shareholding for the Period Ended June 26, 2020
Shareholding Pattern for the Period Ended June 26, 2020. For more details, kindly Click ....
Jun 2020
15 Jun · Board meeting
Meeting on 26 Jun 2020: audited results
May 2020
5 May · Shareholding for the Period Ended March 31, 2020
Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click ....
Apr 2020
29 Apr · Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 2 2 029 Apr · Compliance Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
21 Apr · Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Half Year Ended On March 31, 2020
Mar 2020
2 Mar · Legal
Exchange has sought clarification from Kimia Biosciences Ltd on 02nd March, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Feb 2020
13 Feb · Board meeting
7 Feb · Shareholding for the Period Ended January 28, 2020
Shareholding Pattern for the Period Ended January 28, 2020. For more details, kindly Click ....1 Feb · Board meeting
Meeting on 13 Feb 2020: quarterly results
Jan 2020
29 Jan · Announcement under Regulation 30 (LODR)-Allotment
29 Jan · Announcement under Regulation 30 (LODR)-Allotment
13 Jan · Shareholding for the Period Ended December 31, 2019
Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click ....9 Jan · Statement Of Investor Complaints For The Quarter Ended December 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 1 1 0
Dec 2019
Oct 2019
25 Oct · Submission Of Compliance Certificate Under Regulation 40(9) Of SEBI (LODR) Regulation, 2015.
24 Oct · Results
18 Oct · Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
16 Oct · Shareholding for the Period Ended September 30, 2019
Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click ....11 Oct · Statement Of Investor Complaints For The Quarter Ended September 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 1 1 011 Oct · Board meeting
Meeting on 24 Oct 2019: quarterly results7 Oct · Board meeting
Sep 2019
30 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Aug 2019